Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2012 2
2014 2
2015 2
2016 2
2017 6
2018 7
2019 7
2020 2
2021 4
2022 6
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 12"
Page 1
Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis.
Antonopoulos AS, Panagiotopoulos I, Kouroutzoglou A, Koutsis G, Toskas P, Lazaros G, Toutouzas K, Tousoulis D, Tsioufis K, Vlachopoulos C. Antonopoulos AS, et al. Eur J Heart Fail. 2022 Sep;24(9):1677-1696. doi: 10.1002/ejhf.2589. Epub 2022 Aug 2. Eur J Heart Fail. 2022. PMID: 35730461 Free article.
We identified a total of 62 studies (n = 277 882 individuals) reporting the prevalence of cardiac amyloidosis, which was high among patients with a hypertrophic cardiomyopathy phenotype, heart failure with preserved ejection fraction, and the elderly with aortic ste …
We identified a total of 62 studies (n = 277 882 individuals) reporting the prevalence of cardiac amyloidosis, which was high among patients …
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.
Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, Sinagra G, Emdin M, Rapezzi C. Aimo A, et al. Eur J Heart Fail. 2022 Dec;24(12):2342-2351. doi: 10.1002/ejhf.2532. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35509173 Free PMC article.
The prevalence of CA in different settings was as follows: bone scintigraphy for non-cardiac reasons (n = 5 studies), 1% (95% confidence interval [CI] 0%-1%); heart failure with preserved ejection fraction (n = 6), 12% (95% CI 6%-20%); heart failure with reduced or mildly …
The prevalence of CA in different settings was as follows: bone scintigraphy for non-cardiac reasons (n = 5 studies), 1% (95% confidence int …
Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis.
Ramaswamy VV, Bandyopadhyay T, Nanda D, Bandiya P, Ahmed J, Garg A, Roehr CC, Nangia S. Ramaswamy VV, et al. JAMA Pediatr. 2021 Jun 1;175(6):e206826. doi: 10.1001/jamapediatrics.2020.6826. Epub 2021 Jun 7. JAMA Pediatr. 2021. PMID: 33720274 Free PMC article.
Surface under the cumulative ranking curve (SUCRA) value ranking showed that MoMdDX (SUCRA, 0.91), MoHdDX (SUCRA, 0.86), and LaHdDX (SUCRA, 0.76) were the 3 most beneficial interventions. ITBUD (RR, 4.36; 95% CrI, 1.04-12.90); LaHdDX (RR, 11.91; 95% CrI, 1.64-44.49); LaLdD …
Surface under the cumulative ranking curve (SUCRA) value ranking showed that MoMdDX (SUCRA, 0.91), MoHdDX (SUCRA, 0.86), and LaHdDX (SUCRA, …
Long-term outcome of nonobstructive versus obstructive hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Pelliccia F, Pasceri V, Limongelli G, Autore C, Basso C, Corrado D, Imazio M, Rapezzi C, Sinagra G, Mercuro G; Working Group on Cardiomyopathies and Pericardial Diseases of the Italian Society of Cardiology. Pelliccia F, et al. Int J Cardiol. 2017 Sep 15;243:379-384. doi: 10.1016/j.ijcard.2017.06.071. Int J Cardiol. 2017. PMID: 28747036 Review.
BACKGROUND: Prognosis of hypertrophic cardiomyopathy (HCM) is particularly heterogeneous. Patients with nonobstructive HCM (NOCM) are thought to be at relatively low-risk as compared with obstructive HCM (HOCM) with no need of major treatment options. ...Aim of this …
BACKGROUND: Prognosis of hypertrophic cardiomyopathy (HCM) is particularly heterogeneous. Patients with nonobstructive HCM (NO …
Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
Yang Y, Wu D, Wang H, Wang Y. Yang Y, et al. Clin Cardiol. 2022 Dec;45(12):1184-1191. doi: 10.1002/clc.23928. Epub 2022 Sep 30. Clin Cardiol. 2022. PMID: 36177652 Free PMC article. Review.
BACKGROUND: As previously reported, impairment of left ventricular global longitudinal strain (LVGLS) is associated with myocardial fibrosis, arrhythmias, and heart failure in hypertrophic cardiomyopathy (HCM) patients. HYPOTHESIS: This study aimed to estimate the a …
BACKGROUND: As previously reported, impairment of left ventricular global longitudinal strain (LVGLS) is associated with myocardial fibrosis …
Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
Topriceanu CC, Pereira AC, Moon JC, Captur G, Ho CY. Topriceanu CC, et al. Circulation. 2024 Jan 9;149(2):107-123. doi: 10.1161/CIRCULATIONAHA.123.065987. Epub 2023 Nov 6. Circulation. 2024. PMID: 37929589 Free PMC article.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular hypertrophy and is classically caused by pathogenic or likely pathogenic variants (P/LP) in genes encoding sarcomere proteins. ...However, short-term gene-specific phenoty …
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular hypertrophy and is classically …
Left Ventricular Assist Device Implantation in Hypertrophic and Restrictive Cardiomyopathy: A Systematic Review.
Sreenivasan J, Kaul R, Khan MS, Ranka S, Demmer RT, Yuzefpolskaya M, Aronow WS, Warraich HJ, Pan S, Panza JA, Cooper HA, Naidu SS, Colombo PC. Sreenivasan J, et al. ASAIO J. 2021 Mar 1;67(3):239-244. doi: 10.1097/MAT.0000000000001238. ASAIO J. 2021. PMID: 33627595
Left ventricular assist device (LVAD) implantation in patients with advanced heart failure due to hypertrophic or restrictive cardiomyopathy (HCM/RCM) presents technical and physiologic challenges. ...We identified six studies with a total of 2,766 patients with HCM …
Left ventricular assist device (LVAD) implantation in patients with advanced heart failure due to hypertrophic or restrictive card …
Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis.
Liu Q, Li D, Berger AE, Johns RA, Gao L. Liu Q, et al. Sci Rep. 2017 Sep 20;7(1):11957. doi: 10.1038/s41598-017-12289-4. Sci Rep. 2017. PMID: 28931939 Free PMC article.
Hypertrophic cardiomyopathy (HCM) is a clinically and genetically heterogeneous disorder but data on survival rates are still conflicting and have not so far been quantitatively reviewed. The aim of this study is to conduct a meta-analysis of cohort studies to asses …
Hypertrophic cardiomyopathy (HCM) is a clinically and genetically heterogeneous disorder but data on survival rates are still …
Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta-Analysis.
Zhao H, Tan Z, Liu M, Yu P, Ma J, Li X, Wang J, Zhao Y, Zhu W, Liu X. Zhao H, et al. J Am Heart Assoc. 2023 Jun 6;12(11):e026270. doi: 10.1161/JAHA.122.026270. Epub 2023 May 26. J Am Heart Assoc. 2023. PMID: 37232242 Free PMC article.
Background It is still unclear whether there is a sex difference in the prognosis of patients with hypertrophic cardiomyopathy (HCM). Therefore, we performed a meta-analysis to elucidate the association between sex and adverse outcomes in patients with HCM. ...
Background It is still unclear whether there is a sex difference in the prognosis of patients with hypertrophic cardiomyopathy …
Antimalarial-induced cardiomyopathy: a systematic review of the literature.
Tselios K, Deeb M, Gladman DD, Harvey P, Urowitz MB. Tselios K, et al. Lupus. 2018 Apr;27(4):591-599. doi: 10.1177/0961203317734922. Epub 2017 Oct 9. Lupus. 2018. PMID: 28992800 Review.
Results Forty-seven cases (42 females) were identified with a mean age at diagnosis 56.4 12.6 and mean AM treatment duration 12.7 8.2 years. Systemic lupus erythematosus ( n = 19) and rheumatoid arthritis ( n = 18) were the most common primary diseases. ...Conclusio …
Results Forty-seven cases (42 females) were identified with a mean age at diagnosis 56.4 12.6 and mean AM treatment duration 12 …
43 results